There are no products listed under this category.
STARD8
STARD8 (StAR related lipid transfer domain containing 8, also known as ARHGAP38 and KIAA0189) is a Rho GTPase activating protein that carries a StAR-related lipid transfer (START) domain. It accelerates GTPase activity of RHOA and CDC42 and localises to focal adhesions. Browse Assay Genie's current range of STARD8 research reagents below, or read on for the biology behind the target.
STARD8 is a GTPase activating protein (GAP) for Rho family small GTPases. It accelerates the GTPase activity of RHOA and CDC42, but not RAC1, which is the activity that switches these signalling proteins from their active, GTP-bound state to the inactive state. UniProt also reports that STARD8 stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1, linking Rho GTPase regulation to phosphoinositide turnover.
The STARD8 gene encodes a member of a subfamily of Rho GTPase activating proteins that contain a steroidogenic acute regulatory protein related lipid transfer domain. HGNC places the protein in two gene groups: Rho GTPase activating proteins, and StAR related lipid transfer domain containing. The STARD8 protein is found at focal adhesions, a cell junction compartment, and may be involved in regulating cell morphology. The mouse ortholog is Stard8.
STARD8 is also known as ARHGAP38 and KIAA0189, and its earlier HGNC name was START domain containing 8. The NCBI Gene summary notes that the protein may function as a tumour suppressor, which makes it of interest in studies of cytoskeletal regulation and cancer biology. Other STARD family members, such as STARD13 and STARD10, share the START domain architecture.
STARD8 accelerates GTPase activity of RHOA and CDC42 but not RAC1, making it a useful protein for studying selectivity within Rho family regulation.
The protein localises to focal adhesions, where it may help regulate cell morphology, so it is relevant to studies of adhesion and cytoskeletal organisation.
NCBI Gene reports that STARD8 may function as a tumour suppressor, prompting investigation of its role in tumour biology.
STARD8 stimulates hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1, connecting Rho GAP activity with lipid signalling.
STARD8 is a Rho GTPase activating protein that accelerates GTPase activity of RHOA and CDC42, but not RAC1. It also stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1. It localises to focal adhesions and may regulate cell morphology.
STARD8 is also called ARHGAP38 and KIAA0189. Its previous HGNC name was START domain containing 8, and the current full name is StAR related lipid transfer domain containing 8. UniProt lists the protein as StAR-related lipid transfer protein 8.
NCBI Gene states that STARD8 may function as a tumour suppressor. A mouse ortholog, Stard8, is recorded in the data; check the datasheet of any product for its validated reactivity.
Other START domain proteins that share the lipid transfer domain family with STARD8.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92502; product specifications from Assay Genie datasheets.
There are no products listed under this category.